C
Coeptis Therapeutics Holdings, Inc. (COEP)
NCM – Real Time Price. Currency in USD
16.40
+16.40 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
16.40
+16.40 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.25 | 6.05 | 10 | |
| Quick ratio | 3.25 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | -744.65 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 1M | 1M |
| Gross Profit | -1M | -1M | -1M | -3M | -4M |
| Operating Income | -34M | -21M | -10M | -13M | -13M |
| Net Income | -38M | -21M | -11M | -12M | -12M |
| EBITDA | -33M | -20M | -9M | -12M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | -5.88 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -86.79 | -148.21 | N/A | -4.2 | 1.0 |
| Y/Y | 80.95 | -16.68 | N/A | 25.67 | 5.5 |
| 3y average | 999 | 27.2 | N/A | -35.99 | 5.5 |
| 5y average | 779.2 | -15.11 | N/A | -202.6 | 3.3 |
| Weighted average score | 3.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $5.2M significantly exceed its total debt $343.4K, ensuring strong financial flexibility
Total current assets $5.9M exceed Total current liabilities $1.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-744.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.8M limits the company's ability to reinvest or pay down debt